Video Experimental Relacionado
Updated: May 24, 2026
08:34
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
La terapia antitelomerasa provoca ALT y los mecanismos de adaptación mitocondrial en el cáncer
Jian Hu1, Soyoon Sarah Hwang, Marc Liesa
1Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cell
|February 21, 2012
Resumen
La inhibición de la telomerasa en los linfomas de células T puede conducir a la adaptación del cáncer a través del alargamiento alternativo de los telómeros (ALT). Dirigirse a las vías ALT, como el PGC-1β, junto con la inhibición de la telomerasa puede mejorar el tratamiento del cáncer.
Área de la Ciencia:
- Oncología Oncología.
- Biología Molecular Biología Molecular
- Genética La genética.
Sus antecedentes:
- La telomerasa es crucial para la proliferación de las células cancerosas al mantener la longitud de los telómeros.
- Comprender los mecanismos de adaptación a la inhibición de la telomerasa es vital para desarrollar terapias efectivas contra el cáncer.
Objetivo del estudio:
- Para evaluar la telomerasa como objetivo terapéutico del cáncer.
- Investigar los mecanismos de adaptación, incluido el alargamiento alternativo de los telómeros (ALT), en respuesta a la inhibición de la telomerasa.
Principales métodos:
- Reactivación y extinción modelada de la telomerasa en ratones Atm(-/-) diseñados con transcriptasa inversa telomerasa inducible.
- Analizó las alteraciones del número de copias y las redes transcripcionales en el desarrollo de linfomas de células T.
Principales resultados:
- La reactivación de la telomerasa promovió la progresión maligna y eludió los puntos de control.
- La extinción de la telomerasa inicialmente ralentizó el crecimiento tumoral, pero fue seguida por la adquisición de ALT.
- Los tumores ALT+ exhibieron PGC-1β amplificado y sensibilidad al knockdown de PGC-1β/SOD2.
Conclusiones:
- La inhibición de la telomerasa puede impulsar la adaptación al cáncer mediada por ALT.
- La co-orientación de la biogénesis mitocondrial (PGC-1β) y la defensa oxidativa (SOD2) con inhibidores de la telomerasa puede mejorar las estrategias anticancerígenas.
Videos de Conceptos Relacionados
02:41Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
02:41Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...